PEAK6’s ResMed RMD Stock Holding History

PEAK6’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.21M	Sell	5,400 -6,700	-55%	-$1.67M	﹤0.01%	1609
2025 Q4	$2.91M	Buy	12,100 +4,500	+59%	+$1.15M	0.01%	1225
2025 Q3	$2.08M	Buy	7,600 +2,200	+41%	+$601K	﹤0.01%	1480
2025 Q2	$1.39M	Buy	+5,400	New	+$1.29M	﹤0.01%	1631

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PEAK6's RMD Position: Q2 2025 in Review

PEAK6 sold out of ResMed (RMD) in Q2 2025, closing a stake of 300 shares — an estimated $71.6K sold.

PEAK6 first reported a position in RMD in Q4 2024 and held it in 2 quarters. The position peaked at $716K in Q4 2024. 919 funds tracked by Wall St. Rank hold RMD as of Q2 2025.

PEAK6 reported no remaining ResMed position as of Q2 2025 after selling out during the quarter.
PEAK6 sold 300 ResMed shares in Q2 2025, an estimated $71.6K.
PEAK6 first reported a position in ResMed in Q4 2024 and held it in 2 quarters.
PEAK6's ResMed position peaked at $716K in Q4 2024.
919 funds tracked by Wall St. Rank held ResMed as of Q2 2025.

Based on PEAK6's 13F filing for Q2 2025, filed 14 Aug 2025.